180
Participants
Start Date
June 1, 2022
Primary Completion Date
September 30, 2026
Study Completion Date
September 30, 2027
Atomoxetine Hydrochloride
Atomoxetine 40 mg PO BID (morning and late afternoon) Dosing will start at 40 mg daily for 3 days1 week, followed by a forced titration to 40 mg BID, as per the FDA label for atomoxetine
Placebo
Placebo Comparator: Placebo Matching placebo will be identical in appearance to the active treatment pill. BID (morning and late afternoon)
RECRUITING
University of Calgary, Calgary
University of Calgary
OTHER